Avidity Biosciences develops Antibody Oligonucleotide Conjugates (AOC™) to deliver RNA therapeutics that target the underlying genetic causes of rare muscle diseases such as myotonic dystrophy and Duchenne muscular dystrophy. Their platform enables precise treatment delivery to previously inaccessible tissues, addressing significant unmet medical needs in the field of genetic disorders.

The company provides a High‑Definition PCR (HDPCR™) platform that delivers over four‑fold multiplexing of DNA and RNA biomarkers using standard PCR instruments, enabling comprehensive genomic profiling without dedicated hardware. Its cloud‑based analytics suite automates assay interpretation, quality control, and reporting in a HIPAA‑ and ISO‑compliant environment, offering a faster, lower‑cost alternative to NGS for oncology, MRD, and disease‑monitoring applications in clinical laboratories.

UCAP Power develops ultracapacitor technology using activated carbon from sustainable sources to provide high-power energy storage solutions that replace lead-acid batteries. Their products enhance energy efficiency and reliability across various applications, including automotive and renewable energy systems, while minimizing environmental impact.

The startup offers an in-home health tracker application that employs biotechnology and IoT to measure nutrient levels, hydration, cortisol, and toxins in real-time. This technology enables users to identify deficiencies and receive tailored recommendations for improving their health.

WhiteFox Defense Technologies develops the DroneFox, a counter-drone system that creates an invisible firewall to automatically detect and identify unauthorized unmanned aerial vehicles. This technology provides real-time alerts and enables users to implement targeted mitigation strategies, ensuring safety in airspace where drones may pose a threat.